| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.023 | 0.6 |